| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07018323 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for… |
Trial sites expanded: 136 -> 145 locations |
| 2026-05-27 | NCT06980805 A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT06980805 A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants… |
date change Primary completion moved earlier: 2027-04 -> 2026-10 |
| 2026-05-23 | NCT07018323 A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for… |
Trial sites expanded: 126 -> 136 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07039916 | Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe… | Generalized Myasthenia Gravis | Recruiting |
| Phase 2 | |||
| NCT06727604 | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for… | Graves' Disease | Recruiting |
| NCT06979531 | Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease… | Primary Sjögren's Syndrome | Recruiting |
| NCT07018323 | A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for… | Graves' Disease | Recruiting |
| NCT06754462 | A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult… | Rheumatoid Arthritis | Active, Not Recruiting |
| NCT06980805 | A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants… | Subacute Cutaneous Lupus Erythematosus | Active, Not Recruiting |
| NCT07286006 | A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) | Graves' Disease | Enrolling by Invitation |